Cargando…
Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors
SIMPLE SUMMARY: In recent years, growing evidence has suggested that the gut microbiome can significantly influence antitumor immunity, both within and outside the gastrointestinal tract, thereby affecting the efficacy of immune checkpoint inhibitors (ICIs. A link between microbiota composition and...
Autores principales: | Drommi, Fabiana, Calabrò, Alessia, Vento, Grazia, Pezzino, Gaetana, Cavaliere, Riccardo, Omero, Fausto, Muscolino, Paola, Granata, Barbara, D’Anna, Federica, Silvestris, Nicola, De Pasquale, Claudia, Ferlazzo, Guido, Campana, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252007/ https://www.ncbi.nlm.nih.gov/pubmed/37296855 http://dx.doi.org/10.3390/cancers15112893 |
Ejemplares similares
-
Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review
por: Muscolino, Paola, et al.
Publicado: (2023) -
Drag cells in immunity: Plasmacytoid DCs dress up as cancer cells
por: Bonaccorsi, Irene, et al.
Publicado: (2014) -
Circulating ILC precursors expressing CD62L exhibit a type 2 signature distinctly decreased in psoriatic patients
por: Campana, Stefania, et al.
Publicado: (2021) -
Crosstalk between ILC2s and Th2 CD4(+) T Cells in Lung Disease
por: Mi, Lan-lan, et al.
Publicado: (2022) -
Crosstalk between ILC2s and Th2 cells varies among mouse models
por: Gurram, Rama K., et al.
Publicado: (2023)